Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
UH ›
UHIFZO
Trademark search for:
UHIFZO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-10-23 — Application filed
2019-10-26 — Application filed
2019-10-29 — Application filed
2020-01-07 — Assigned to examiner
2020-01-08 — Final disposition recorded
2020-01-08 — Final disposition recorded
2020-01-08 — Final disposition recorded
2020-06-08 — Office action issued
2020-06-08 — Correspondence received in law office
2020-06-09 — Teas/email correspondence entered
2020-06-18 — Approved for pub - principal register
2020-06-22 — Assigned to lie
2020-07-08 — Notification of notice of publication e-mailed
2020-07-28 — Published for opposition
2020-07-28 — Official gazette publication confirmation e-mailed
2020-09-22 — Noa e-mailed - sou required from applicant
2021-02-12 — Sou teas extension received
2021-02-12 — Sou extension 1 filed
2021-02-12 — Sou extension 1 granted
2021-02-16 — Notice of approval of extension request e-mailed
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas change of correspondence received
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2021-08-10 — Sou teas extension received
2021-08-10 — Sou extension 2 filed
2021-08-10 — Sou extension 2 granted
2021-08-12 — Notice of approval of extension request e-mailed
2022-02-14 — Sou teas extension received
2022-02-14 — Sou extension 3 filed
2022-02-14 — Sou extension 3 granted
2022-02-16 — Notice of approval of extension request e-mailed
2022-09-12 — Sou teas extension received
2022-09-12 — Sou extension 4 granted
2022-09-12 — Sou extension 4 filed
2022-09-14 — Notice of approval of extension request e-mailed
2023-03-17 — Sou teas extension received
2023-03-17 — Sou extension 5 filed
2023-03-29 — Case assigned to intent to use paralegal
2023-03-29 — Sou extension 5 granted
2023-03-30 — Notice of approval of extension request e-mailed
2023-10-23 — Application abandoned
2023-10-23 — Application abandoned
2023-10-23 — Final status recorded
Owner Information
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP 1800 Concord Pike, A2C Wilmington, DE 19850-5437 UNITED STATES
Filing Details
Filing Date:
2019-10-23
Status Date:
2023-10-23
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.